Advances of Platelet-Rich Plasma in Female Infertility

DOI: https://doi.org/10.62517/jmhs.202405317

Author(s)

Rui Xu1, Lifeng Xu2, Zhenmin Sun1, Jun Wang1,*

Affiliation(s)

1Department of Blood Transfusion, Peking University Third Hospital, Beijing, China 2Department of Clinical Lab, Haidian District Maternal and Child Health Care Hospital, Beijing, China *Corresponding Author.

Abstract

As a critical complex of autologous endogenous growth factors, platelet-rich plasma (PRP) has biological functions such as promoting tissue repair, regeneration, angiogenesis, anti-inflammatory, immune regulation and so on. PRP is used in various clinical fields, as its application continues to expand, gradually introduced into the field of female reproduction. In recent years, an enormous number of literatures have been reported at home and abroad that, PRP therapy, serving as a novel assisted reproductive technology, has achieved certain advancements in the treatment of female infertility. Platelet-rich plasma holds definite potential in the realm of infertility treatment. It can promote tissue repair, improve reproductive system function, and bring new hope for infertility patients. To provide a new direction for the studies and therapeutic strategies of female infertility, this review summarizes the functions and related mechanisms of PRP in clinical practice, as well as recent advances of PRP for the treatment of female infertility.

Keywords

Platelet-Rich Plasma; reproductive Medicine; Assisted Reproductive Technology; Female Infertility; Recurrent Implantation Failure

References

[1] Everts P, Onishi K, Jayaram P, et al. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020 Oct 21; 21(20): 7794. [2] Manini DR, Shega FD, Guo C, et al. Role of Platelet-Rich Plasma in Spinal Fusion Surgery: Systematic Review and Meta-Analysis. Adv Orthop. 2020 May 6; 2020: 8361798. [3] Li J, Li Z, Wang C, et al. The Regulatory Effect of VEGF-Ax on Rat Bone Marrow Mesenchymal Stem Cells' Angioblastic Differentiation and Its Proangiogenic Ability. Stem Cells Dev. 2020 May 15; 29(10): 667-677. [4] Milants C, Bruyère O, Kaux JF. Responders to Platelet-Rich Plasma in Osteoarthritis: A Technical Analysis. Biomed Res Int. 2017; 2017: 7538604. [5] Maruyama M, Rhee C, Utsunomiya T, et al. Modulation of the Inflammatory Response and Bone Healing. Front Endocrinol (Lausanne). 2020 Jun 11; 11: 386. [6] Teot L, Ohura N. Challenges and Management in Wound Care. Plast Reconstr Surg. 2021 Jan 1; 147(1S-1): 9S-15S. [7] Yin S, Yang X, Bi H, et al. Combined Use of Autologous Stromal Vascular Fraction Cells and Platelet-Rich Plasma for Chronic Ulceration of the Diabetic Lower Limb Improves Wound Healing. Int J Low Extrem Wounds. 2021 Jun; 20(2): 135-142. [8] Vun J, Iqbal N, Jones E, et al. Anti-Aging Potential of Platelet Rich Plasma (PRP): Evidence from Osteoarthritis (OA) and Applications in Senescence and Inflammaging. Bioengineering (Basel). 2023 Aug 21; 10(8): 987. [9] Albalat W, Ebrahim HM. Evaluation of platelet-rich plasma vs intralesional steroid in treatment of alopecia areata. J Cosmet Dermatol. 2019 Oct; 18(5): 1456-1462. [10] Di Guardo F, Blockeel C, De Vos M, et al. Poor ovarian response and the possible role of natural and modified natural cycles. Ther Adv Reprod Health. 2022 Jan 14-16. [11] Cakiroglu Y, Yuceturk A, Karaosmanoglu O, et al. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). Aging (Albany NY). 2022 Mar 22; 14(6): 2513-2523. [12] Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency. Reprod Sci. 2021 Jul; 28(7): 2050-2059. [13] Herlihy NS, Seli E. The use of intraovarian injection of autologous platelet rich plasma (PRP) in patients with poor ovarian response and premature ovarian insufficiency. Curr Opin Obstet Gynecol. 2022 Jun 1; 34(3): 133-137. [14] Hsu CC, Hsu L, Hsu I, et al. Live Birth in Woman with Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report. Front Endocrinol (Lausanne). 2020 Feb 19; 11: 50. [15] Bakacak M, Bostanci MS, İnanc F, et al. Protective Effect of Platelet Rich Plasma on Experimental Ischemia/Reperfusion Injury in Rat Ovary. Gynecol Obstet Invest. 2016; 81(3): 225-31. [16] Li X, Kodithuwakku SP, Chan RWS, et al. Three-dimensional culture models of human endometrium for studying trophoblast-endometrium interaction during implantation. Reprod Biol Endocrinol. 2022 Aug 13; 20(1): 120. [17] Du J, Lu H, Yu X, et al. Efficacy and safety of platelet-rich plasma for the treatment of thin endometrium: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020 Jan;99(3): e18848. [18] Colombo GVL, Fanton V, Sosa D, et al. Use of platelet rich plasma in human infertility. J Biol Regul Homeost Agents. 2017 APR-JUN; 31(2 Suppl. 2): 179-182. [19] Kim H, Shin JE, Koo HS, et al. Effect of Autologous Platelet-Rich Plasma Treatment on Refractory Thin Endometrium during the Frozen Embryo Transfer Cycle: A Pilot Study. Front Endocrinol (Lausanne). 2019 Feb 14; 10:61. [20] Aghajanova L, Houshdaran S, Balayan S, et al. In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial regeneration. J Assist Reprod Genet. 2018 May; 35(5): 757-770. [21] Hajipour H, Farzadi L, Latifi Z, et al. An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: clinical and molecular aspects. Syst Biol Reprod Med. 2021 Jun; 67(3): 177-188. [22] Chang Y, Peng J, Zhu Y, et al. How platelet-rich plasma (PRP) intra-uterine injection improve endometrial receptivity of intrauterine adhesions in women: A time-series-based self-controlled study. J Reprod Immunol. 2023 Mar; 156: 103796. [23] Albazee E, Al-Rshoud F, Almahmoud L, et al. Platelet-rich plasma for the management of intrauterine adhesions: A systematic review and meta-analysis of randomized controlled trials. J Gynecol Obstet Hum Reprod. 2022 Feb; 51(2): 102276. [24] Benkhalifa M, Joao F, Duval C, Montjean D, et al. Endometrium Immunomodulation to Prevent Recurrent Implantation Failure in Assisted Reproductive Technology. Int J Mol Sci. 2022 Oct 24; 23(21): 12787. [25] Franasiak JM, Alecsandru D, Forman EJ, et al. A review of the pathophysiology of recurrent implantation failure. Fertil Steril. 2021 Dec; 116(6): 1436-1448. [26] Enatsu Y, Enatsu N, Kishi K, et al. Clinical outcome of intrauterine infusion of platelet-rich plasma in patients with recurrent implantation failure. Reprod Med Biol. 2021 Sep 30; 21(1): e12417. [27] Nazari L, Salehpour S, Hoseini S, et al. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. Int J Reprod Biomed. 2016 Oct; 14(10): 625-628. [28] Kong X, Tang G, Liu Y, et al. Efficacy of intrauterine infusion therapy before embryo transfer in recurrent implantation failure: A systematic review and network meta-analysis. J Reprod Immunol. 2023 Mar; 156: 103819.